NFLX
76
-3
SE
63
2
BEN
50
4
KHC
20
-4
SPG
56
-4
PEG
71
6
NTRS
59
2
LH
48
5
PHM
70
11
UNH
63
4
DVA
76
3
ADI
52
5
MHK
55
6
TAP
61
3
PEP
50
2
GME
70
4
ES
38
4
SRE
54
-12
TXN
46
4
PVH
67
5
NFLX
76
-3
SE
63
2
BEN
50
4
KHC
20
-4
SPG
56
-4
PEG
71
6
NTRS
59
2
LH
48
5
PHM
70
11
UNH
63
4
DVA
76
3
ADI
52
5
MHK
55
6
TAP
61
3
PEP
50
2
GME
70
4
ES
38
4
SRE
54
-12
TXN
46
4
PVH
67
5
Financhill
Back

Bioage Labs 10K Form

Sell
43

BIOA
Bioage Labs

Last Price:
19.63
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOA News And Ratings

See the #1 stock for the next 7 days that we like better than BIOA

BIOA Financial Statistics

Sales & Book Value

Annual Sales: $14.94M
Cash Flow: $-15.82M
Price / Cash Flow: 0
Annual Sales: $-6.38
Price / Book: 0

Profitability

EPS (TTM): -1.77420
Net Income (TTM): $-54.84M
Gross Margin: $-7.38M
Return on Equity: 0%
Return on Assets: 0%

Bioage Labs Earnings Forecast

Key Bioage Labs Financial Ratios

  • The Gross Profit Margin over the past 5 years for BIOA is -49.40%.
  • The Selling, General & Administrative Expenses for BIOA have been equal to 95.65% of Gross Profit Margin.
  • The Interest Expense is -12.21% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Bioage Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BIOA
CUSIP: 09072Q
Website: bioagelabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIOA Technical Analysis vs Fundamental Analysis

Sell
43
Bioage Labs (BIOA) is a Sell

Is Bioage Labs a Buy or a Sell?

  • Bioage Labs stock is rated a Sell
    The current Bioage Labs [BIOA] share price is $19.07. The Score for BIOA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.